News Medical

Luminex's NxTAG Respiratory Pathogen Panel receives CE-IVD marking

Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for its NxTAG® Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial ...
Business Wire

Integrated DNA Technologies Launches New Respiratory Virus Panel

CORALVILLE, Iowa--(BUSINESS WIRE)--To meet customer demand for a multiplexed, multiple respiratory disease target panel that provides comprehensive genome coverage, Integrated DNA Technologies (IDT) ...
The Bakersfield Californian

Applied BioCode Submits BioCode® Respiratory Pathogen Panel (RPP) with KingFisher™ Nucleic Acid Extraction Claim to the FDA

Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction claim for the KingFisher™ Flex Nucleic Acid Purification System ...
Healio

FDA clears Qiagen’s respiratory syndromic testing panel

Please provide your email address to receive an email when new articles are posted on . Qiagen’s respiratory panel can detect 21 viral and bacterial pathogens that can cause upper respiratory ...
Becker's Hospital Review

Georgia lab completes validation of combination respiratory test panel

Alpharetta, Ga.-based Provista Diagnostics, a clinical diagnostics lab owned by medical diagnostics company Todos Medical, cleared all necessary hurdles to begin producing its new respiratory test ...
Nasdaq

Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2

AUSTIN, Texas, March 4, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) ...